Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 4 | 3 | 11 | 10 |
| Receivables | 1 | 3 | 7 | 6 | 5 |
| Inventories | N/A | N/A | N/A | 0 | 160 |
| TOTAL | $21 | $35 | $50 | $39 | $226 |
| Non-Current Assets | |||||
| Intangibles | 6 | 6 | 6 | 7 | 7 |
| TOTAL | $6 | $6 | $6 | $7 | $7 |
| Total Assets | $27 | $42 | $56 | $46 | $233 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,023 | 965 | 908 | 816 | 739 |
| Accounts payable and accrued liabilities | 173 | 167 | 172 | 150 | 264 |
| Accrued Expenses | 15 | 10 | 13 | 20 | 15 |
| Other current liabilities | 242 | 242 | 253 | 244 | 579 |
| TOTAL | $1,453 | $1,384 | $1,347 | $1,229 | $1,597 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,453 | $1,384 | $1,347 | $1,229 | $1,597 |
| Shareholders' Equity | |||||
| Common Shares | 9,701 | 9,701 | 9,701 | 9,701 | 9,701 |
| Retained earnings | -12,447 | -12,363 | -12,311 | -12,204 | -12,358 |
| Other shareholders' equity | 1,320 | 1,320 | 1,320 | 1,320 | 1,293 |
| TOTAL | $-1,426 | $-1,342 | $-1,290 | $-1,183 | $-1,365 |
| Total Liabilities And Equity | $27 | $42 | $56 | $46 | $233 |